The five-year overall survival ranges from 50% to 70% [10,11,12,13] The risk factors for metastatic disease additionally to germline SDHB-mutation comprise of noradrenergic or dopaminergic phenotype, size (>5 cm), and extra-adrenal location [14,15,16]. The gene discussed is SDHB; the disease is metastatic neoplasm.